maintenance chemotherapy

maintenance chemotherapy

The administration of a chemotherapeutic regimen on an ongoing basis after managing a cancer in a traditional manner (e.g., with surgery, radiation or conventional chemotherapy).
 
Adverse effects
Neutropaenia, pancytopaenia, nausea, vomiting, myelodysplastic syndrome, peripheral neuropathy. In the long term, secondary malignancies.

maintenance chemotherapy

Oncology The administration of a chemotherapeutic regimen on an ongoing basis after managing the CA in a traditional manner–eg, with surgery, RT, or conventional chemotherapy Adverse effects Neutropenia, pancytopenia, N&V, myelodysplastic syndrome,  peripheral neuropathy. Cf Adjuvant chemotherapy, Consolidation chemotherapy, Induction chemotherapy, Intensification chemotherapy, Salvage chemotherapy. Cf Adjuvant chemotherapy.
References in periodicals archive ?
Bavarian Nordic A/S (CPH:BAVA) (OTC: BVNRY), a fully integrated biotechnology company, announced on Friday the dosing of the first patient in a clinical study evaluating CV301, the company's targeted immunotherapy candidate, and durvalumab, AstraZeneca's PD-L1 inhibitor, in combination with maintenance chemotherapy, for patients with metastatic colorectal or pancreatic cancers.
Now she's on maintenance chemotherapy until February."
NewLink Genetics reported that updated Phase 1 data evaluating indoximod plus front-line radiation and maintenance chemotherapy for the treatment of pediatric patients with newly diagnosed diffuse intrinsic pontine glioma, or DIPG, were presented at the International Symposium of Pediatric Neuro-Oncology, or ISPNO.
While we failed to prove the true benefits of supplements, such as vitamin E or UDCA, in addition to chemotherapy, further studies should be conducted to evaluate the long-term benefit of these adjuvant therapies during the maintenance chemotherapy for the evaluation of survival outcomes, including disease-free and overall survival.
He then had maintenance chemotherapy for 18 months - but in April 2013 Louise and teacher husband Scott, 40, were told the cancer had spread into his central nervous system.
A 20-year-old man was referred to our institution from an oncological clinic where he was undergoing maintenance chemotherapy for metastatic alveolar rhabdomyosarcoma.
Subsequently, he was switched to pyrimethamine, leucovorin, and atovaquone as secondary prophylaxis for toxoplasma infection while he was lymphopenic during ongoing maintenance chemotherapy. The patient died 30 months after HSCT due to progressive myeloma with no evidence of toxoplasmosis.
She started maintenance chemotherapy, in addition to intrathecal therapy (no blasts in the CNS fluid) as a bridge to allo-HSCT.
Following a series of tests, doctors recommended that Brenz undergo maintenance chemotherapy sessions.
She then continued on so-called maintenance chemotherapy for a further year and began to rebuild her life.
The patient received 8 cycles of chemotherapy and is currently receiving maintenance chemotherapy with methotrexate and 6-mercaptopurine.
Metronomic maintenance chemotherapy consisted of oral Cyclophosphamide (50 mg PO daily) and methotrexate (2.5 mg PO BID on days 1 and 2 of each week).

Full browser ?